{"id":1067932,"date":"2020-11-22T13:59:45","date_gmt":"2020-11-22T18:59:45","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/affimed-announces-publication-of-final-study-results-of-its-innate-cell-engager-candidate-afm13-in-combination-with-msds-anti-pd-1-therapy\/"},"modified":"2024-08-18T11:41:04","modified_gmt":"2024-08-18T15:41:04","slug":"affimed-announces-publication-of-final-study-results-of-its-innate-cell-engager-candidate-afm13-in-combination-with-msds-anti-pd-1-therapy","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/affimed-announces-publication-of-final-study-results-of-its-innate-cell-engager-candidate-afm13-in-combination-with-msds-anti-pd-1-therapy.php","title":{"rendered":"Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD\u2019s anti-PD-1 therapy&#8230;"},"content":{"rendered":"<p><![CDATA[]]><\/p>\n<p>See the original post here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/19\/2130514\/0\/en\/Affimed-Announces-Publication-of-Final-Study-Results-of-its-Innate-Cell-Engager-Candidate-AFM13-in-Combination-with-MSD-s-anti-PD-1-therapy-KEYTRUDA-pembrolizumab-in-Blood.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD\u2019s anti-PD-1 therapy...\">Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD\u2019s anti-PD-1 therapy...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the original post here: Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD\u2019s anti-PD-1 therapy... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/affimed-announces-publication-of-final-study-results-of-its-innate-cell-engager-candidate-afm13-in-combination-with-msds-anti-pd-1-therapy.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1067932","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067932"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1067932"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067932\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1067932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1067932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1067932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}